MDXH Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - MDxHealth SA - Alpha Spread
M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 2.63 USD 2.33% Market Closed
Market Cap: 71.8m USD
Have any thoughts about
MDxHealth SA?
Write Note

Wall Street
Price Targets

MDXH Price Targets Summary
MDxHealth SA

Wall Street analysts forecast MDXH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDXH is 8.98 USD with a low forecast of 6.06 USD and a high forecast of 15.75 USD.

Lowest
Price Target
6.06 USD
130% Upside
Average
Price Target
8.98 USD
241% Upside
Highest
Price Target
15.75 USD
499% Upside
MDxHealth SA Competitors:
Price Targets
MIRM
Mirum Pharmaceuticals Inc
59% Upside
CDMO
Avid Bioservices Inc
2% Upside
SIGHT
Gensight Biologics SA
2% Downside
NTRA
Natera Inc
4% Upside
VRDN
Viridian Therapeutics Inc
60% Upside
DSGN
Design Therapeutics Inc
22% Upside
4142
Adimmune Corp
28% Upside
LEGN
Legend Biotech Corp
67% Upside

Revenue
Forecast

Revenue Estimate
MDxHealth SA

For the last 8 years the compound annual growth rate for MDxHealth SA's revenue is 19%. The projected CAGR for the next 3 years is 17%.

19%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
MDxHealth SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
58%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDXH's stock price target?
Price Target
8.98 USD

According to Wall Street analysts, the average 1-year price target for MDXH is 8.98 USD with a low forecast of 6.06 USD and a high forecast of 15.75 USD.

What is MDxHealth SA's Revenue forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for MDxHealth SA's revenue is 19%. The projected CAGR for the next 3 years is 17%.

Back to Top